Fluctuating results may have caused patience with GN Hearing CEO's Gitte Aabo to run out among some of the company's big investors and analysts, reports the media Insidebusiness.
According to the media, more institutional investors have expressed their disappointment over the recent developments at GN Hearing, the latest of which was the October full-year financial guidance downgrade after two key products weren't ready on time. They also reportedly find the company and Aabo's communication skills lacking.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
GN purchase story is very speculative, says analyst
Competition rules could block a purchase of GN Store Nord and subsequent divestment of GN Hearing, says a Sydbank analyst on the speculative story that this might be underway.
Novo Nordisk invests additional millions of dollars in new manufacturing facilities
Novo Nordisk’s DKK 17bn (USD 2.4bn) investment into upgrading and building new facilities in Kalundborg last year has now been followed by a DKK 1bn (USD 143.8m) investment in the same location.
Long wait for IVDR implementation is over, putting an end to pandemic "wild west"
After prolonged debates on potential bottlenecking and supply issues, the EU’s long-awaited In Vitro Diagnostic Medical Devices Regulation comes into force on May 26.
Bavarian Nordic upgrades guidance following vaccine contract
Bavarian has been the center of attention in recent days due to its monkeypox vaccine, and the company has now secured a vaccine contract with another undisclosed country. Consequently, Bavarian has raised its expectations for the full year.
US to start using Bavarian vaccine stockpile
In an attempt to contain a monkeypox outbreak, US authorities will start offering certain people Bavarian Nordic-developed Jynneos vaccinations against the infectious disease.
Senior QA Specialist 
Senior Project Manager (GMP - Life Science) 
Laboratory technician for process development and clinical manufacturing 
Production Director 
2 Sales Representatives and Product Specialists 
Director for innovative pre-clinical testing unit 
Biomarker Operations Lead 
Clinical Trial Manager for development of in vitro diagnostics 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Industrial Designer- Design Engineer 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
System Sales Development Consultant - Investment Projects, Merck Millipore 
Client Talent Acquisition Specialist 
Senior Chemical Safety Advisor 
Clinical Trial Manager